Nash Duane

Average Profitability
26.35%
Insider Buys Quantity
5
Insider Buys Sum
$138,964.08
Insider Sells Quantity
15
Insider Sells Sum
$750,205.23

Insider Activity of Nash Duane

The largest purchase of all time was on 2021-05-12 and amounted to 4000 shares of Immunic, Inc. for $51,000.

The largest sale of all time was on 2014-12-24 and amounted to 20292 shares of Akebia Therapeutics, Inc. for $228,567.

Biography of Nash Duane

No biography is available at this moment.

2022-05-12PurchaseImmunic, Inc.
IMUX
Executive Chairman
10,000
0.0323%
$5.03$50,300-59.81%
2021-08-10PurchaseImmunic, Inc.
IMUX
Executive Chairman
1,000
0.004%
$9.80$9,800-5.42%
2021-05-12PurchaseImmunic, Inc.
IMUX
Executive Chairman
4,000
0.0186%
$12.75$51,000-21.89%
2019-12-04SaleImmunic, Inc.
IMUX
director
4,400
0.0423%
$6.96$30,624+75.82%
2018-02-15SaleAkebia Therapeutics, Inc.
AKBA
director
2,000
0.0041%
$14.62$29,240-39.72%
2017-10-02SaleAkebia Therapeutics, Inc.
AKBA
director
2,376
0.0049%
$19.64$46,665-45.25%
2017-07-03SaleAkebia Therapeutics, Inc.
AKBA
director
1,980
0.0041%
$14.27$28,255-0.51%
2017-06-08PurchaseImmunic, Inc.
IMUX
President
7,800
0.0186%
$3.12$24,364+74.6%
2017-04-03SaleAkebia Therapeutics, Inc.
AKBA
director
1,982
0.005%
$9.20$18,239+64.77%
2017-01-03SaleAkebia Therapeutics, Inc.
AKBA
director
3,960
0.0102%
$10.46$41,422+33.48%
2016-10-03SaleAkebia Therapeutics, Inc.
AKBA
director
3,962
0.0105%
$8.96$35,492+14.51%
2016-07-06SaleAkebia Therapeutics, Inc.
AKBA
director
3,960
0.0098%
$7.48$29,637+14.7%
2015-10-02SaleAkebia Therapeutics, Inc.
AKBA
director
1,992
0.0066%
$8.65$17,235-11.81%
2015-07-02SaleAkebia Therapeutics, Inc.
AKBA
director
1,992
0.0067%
$9.53$18,980-8.32%
2015-04-02SaleAkebia Therapeutics, Inc.
AKBA
director
1,992
0.0074%
$9.09$18,104-4.68%
2015-01-02SaleAkebia Therapeutics, Inc.
AKBA
director
1,990
0.0099%
$11.46$22,807-16.09%
2015-01-01SaleAkebia Therapeutics, Inc.
AKBA
director
995
0.0049%
$11.46$11,403-16.09%
2014-12-26SaleAkebia Therapeutics, Inc.
AKBA
director
15,507
0.0754%
$11.19$173,537-16.01%
2014-12-24SaleAkebia Therapeutics, Inc.
AKBA
director
20,292
0.1016%
$11.26$228,567-14.07%
2014-10-08PurchaseImmunic, Inc.
IMUX
See Remarks
200
0.0014%
$17.50$3,500+32.81%
Total: 20
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.